Management of type 2 diabetes mellitus in children and adolescents

Pediatrics

Volumn 131, Issue 2, 2013, Pages

  Springer, Shelley C ^a   Silverstein, Janet ^a   Copeland, Kenneth ^a   Moore, Kelly R ^a   Prazar, Greg E ^a   Raymer, Terry ^a   Shiffman, Richard N ^a   Thaker, Vidhu V ^a   Anderson, Meaghan ^a   Spann, Stephen J ^a   Flinn, Susan K ^a  

^a NONE

Author keywords

Childhood; Clinical practice guidelines; Comanagement; Diabetes; Management; Treatment; Type 2 diabetes mellitus; Youth

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLITAZONE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C;

AGE; ARTICLE; AUTOIMMUNITY; BLOOD PRESSURE MEASUREMENT; BONE DISEASE; CHILD HEALTH CARE; COMORBIDITY; COUGHING; DEPRESSION; DIABETIC KETOACIDOSIS; DIABETIC RETINOPATHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSLIPIDEMIA; ENDOCRINOLOGIST; ETHNIC GROUP; EVIDENCE BASED MEDICINE; FAMILY HISTORY; GENERAL PRACTITIONER; GLUCOSE BLOOD LEVEL; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; LASER COAGULATION; MEDICAL PRACTICE; MEDICAL SOCIETY; MEDICAL SPECIALIST; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; OPHTHALMOLOGY; PATIENT REFERRAL; PEDIATRICIAN; POVERTY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RACE; SCREENING; SLEEP DISORDERED BREATHING; SMOKING CESSATION; SODIUM RESTRICTION; SYSTEMATIC REVIEW; TREATMENT FAILURE; WEIGHT REDUCTION;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; COMORBIDITY; COOPERATIVE BEHAVIOR; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; EXPERT TESTIMONY; FEMALE; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; OBESITY; OVERWEIGHT; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84873482025     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2012-3496     Document Type: Article

References (79)

1. Silverstein JH, Rosenbloom AL. Type 2 diabetes in children. Curr Diab Rep. 2001;1(1):19-27
2. Pinhas-Hamiel O, Zeitler P. Clinical presentation and treatment of type 2 diabetes in children. Pediatr Diabetes. 2007;8(9 suppl 9):16-27
3. Dabelea D, Bell RA, D'Agostino RB Jr, et al Writing Group for the SEARCH for Diabetes in Youth Study Group. Incidence of diabetes in youth in the United States. JAMA. 2007; 297(24):2716-2724
4. Mayer-Davis EJ, Bell RA, Dabelea D, et al SEARCH for Diabetes in Youth Study Group. The many faces of diabetes in American youth: Type 1 and type 2 diabetes in five race and ethnic populations: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2009;32(2 suppl 2):S99-S101
5. Liese AD, D'Agostino RB, Jr, Hamman RF, et al SEARCH for Diabetes in Youth Study Group. The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118(4):1510-1518
6. Narayan KM, Williams R. Diabetes-a global problem needing global solutions. Prim Care Diabetes. 2009;3(1):3-4
7. Silverstein J, Klingensmith G, Copeland K, et al American Diabetes Association. Care of children and adolescents with type 1 diabetes: A statement of the American Diabetes Association. Diabetes Care. 2005;28 (1):186-212
8. Pinhas-Hamiel O, Zeitler P. Barriers to the treatment of adolescent type 2 diabetes-a survey of provider perceptions. Pediatr Diabetes. 2003;4(1):24-28
9. TODAY Study Group, Zeitler P, Epstein L, Grey M, et alTreatment options for type 2 diabetes in adolescents and youth: A study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes. 2007;8 (2):74-87
10. Kane MP, Abu-Baker A, Busch RS. The utility of oral diabetes medications in type 2 diabetes of the young. Curr Diabetes Rev. 2005;1(1):83-92
11. Kaufman FR. Type 2 diabetes mellitus in children and youth: A new epidemic. J Pediatr Endocrinol Metab. 2002;15(suppl 2): 737-744
12. Silverstein JH. Workforce issues for pediatric endocrinology. J Pediatr. 2006;149(1): A3
13. American Board of Pediatrics. 2011 Endocrinology examination. Available at: Https://www.abp.org/abpwebsite/stats/wrkfrc/endo. ppt. Accessed December 20, 2012
14. National Association of Children's Hospitals and Related Institutions. Pediatric Subspecialists Survey Results. Alexandria, VA: National Association of Children's Hospitals and Related Institutions; 2004
15. Saudek CD. The role of primary care professionals in managing diabetes. Clin Diabetes. 2002;20(2):65-66
16. Libman IM, Arslanian SA. Prevention and treatment of type 2 diabetes in youth. Horm Res. 2007;67(1):22-34
17. Gungor N, Hannon T, Libman I, Bacha F, Arslanian S. Type 2 diabetes mellitus in youth: The complete picture to date. Pediatr Clin North Am. 2005;52(6):1579-1609
18. Hannon TS, Rao G, Arslanian SA. Childhood obesity and type 2 diabetes mellitus. Pediatrics. 2005;116(2):473-480
19. Kawahara R, Amemiya T, Yoshino M, Miyamae M, Sasamoto K, Omori Y. Dropout of young non-insulin-dependent diabetics from diabetic care. Diabetes Res Clin Pract. 1994;24 (3):181-185
20. Malasanos TH, Burlingame JB, Youngblade L, Patel BD, Muir AB. Improved access to subspecialist diabetes care by telemedicine: Cost savings and care measures in the first two years of the FITE diabetes project. J Telemed Telecare. 2005;11(suppl 1):74-76
21. Greenfield S, Rogers W, Mangotich M, Carney MF, Tarlov AR. Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialties. Results from the medical outcomes study. JAMA. 1995;274(18):1436-1444
22. Ziemer DC, Tsui C, Caudle J, Barnes CS, Dames F, Phillips LS. An informaticssupported intervention improves diabetes control in a primary care setting. AMIA Annu Symp Proc. 2006:1160
23. Ziemer DC, Miller CD, Rhee MK, et al. Clinical inertia contributes to poor diabetes control in a primary care setting. Diabetes Educ. 2005;31(4):564-571
24. De Berardis G, Pellegrini F, Franciosi M, et al; QuED Study. Quality of care and outcomes in type 2 diabetic patients: A comparison between general practice and diabetes clinics. Diabetes Care. 2004;27(2): 398-406
25. Copeland KC, Zeitler P, Geffner M, et al TODAY Study Group. Characteristics of adolescents and youth with recent-onset type 2 diabetes: The TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96(1):159-167
26. Scott CR, Smith JM, Cradock MM, Pihoker C. Characteristics of youth-onset noninsulindependent diabetes mellitus and insulindependent diabetes mellitus at diagnosis. Pediatrics. 1997;100(1):84-91
27. Libman IM, Pietropaolo M, Arslanian SA, LaPorte RE, Becker DJ. Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care. 2003;26(10):2871-2875
28. Centre for Evidence-based Medicine. Levels of Evidence. Oxford, England: Centre for Evidence-based Medicine; March 2009
29. American Academy of Pediatrics Steering Committee on Quality Improvement and Management. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114(3):874-877
30. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: A systematic review. JAMA. 2005;293(10):1223-1238
31. Shiffman RN, Michel G, Essaihi A. Bridging the guideline implementation gap: A systematic, document-centered approach to guideline implementation. J Am Med Inform Assoc. 2004;11(5):418-426
32. National Library of Medicine. SNOMED clinical terms. Available at: Www.nlm.nih.gov/research/umls/Snomed/snomed-main.html. Accessed August 13, 2012
33. National Library of Medicine. RxNorm. Available at: Www.nlm.nih.gov/ research/umls/rxnorm/. Accessed August 13, 2012
34. Regenstrief Institute. Logical observations identifiers names and codes. Available at: Http://loinc.org/. Accessed August 13, 2012
35. National Quality Forum. Health Information Technology Automation of Quality Measurement: Quality Data Set and Data Flow. Washington, DC: National Quality Forum; 2009
36. American Academy of Pediatrics. Subcommittee on Type 2 Diabetes. Diabetes mellitus, type 2: Clinical practice guideline for the management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents. Pediatrics. 2013, In press
37. Shear CL, Burke GL, Freedman DS, Berenson GS. Value of childhood blood pressure measurements and family history in predicting future blood pressure status: Results from 8 years of follow-up in the Bogalusa Heart Study. Pediatrics. 1986;77(6):862-869
38. Williams CL, Hayman LL, Daniels SR, et al American Heart Association. Cardiovascular health in childhood: A statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association [published correction appears in Circulation. 2002;106 (9):1178]. Circulation. 2002;106(1):143-160
39. Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006;29(6): 1300-1306
40. Mayer-Davis EJ, Ma B, Lawson A, et al SEARCH for Diabetes in Youth Study Group. Cardiovascular disease risk factors in youth with type 1 and type 2 diabetes: Implications of a factor analysis of clustering. Metab Syndr Relat Disord. 2009;7(2): 89-95
41. Hansen ML, Gunn PW, Kaelber DC. Underdiagnosis of hypertension in children and adolescents. JAMA. 2007;298(8):874-879
42. National Heart, Lung and Blood Institute. Blood pressure tables for children and adolescents. Available at: Www.nhlbi.nih. gov/guidelines/ hypertension/child-tbl.htm. Accessed August 13, 2012
43. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004; 114(2 suppl 4th report):555-576
44. Brady TM, Feld LG. Pediatric approach to hypertension. Semin Nephrol. 2009;29(4): 379-388
45. Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998;351(9118): 1755-1762
46. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703-713
47. Yoon EY, Davis MM, Rocchini A, Kershaw D, Freed GL. Medical management of children with primary hypertension by pediatric subspecialists. Pediatr Nephrol. 2009;24(1): 147-153
48. Zanchetti A, Hansson L, Ménard J, et al. Risk assessment and treatment benefit in intensively treated hypertensive patients of the Hypertension Optimal Treatment (HOT) study. J Hypertens. 2001;19(4):819-825
49. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet. 2007;369(9575):1823-1831
50. Rodriguez BL, Fujimoto WY, Mayer-Davis EJ, et al. Prevalence of cardiovascular disease risk factors in U.S. children and adolescents with diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2006; 29(8):1891-1896
51. Kavey RE, Allada V, Daniels SR, et al American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation. 2006;114(24):2710-2738
52. American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care. 2003; 26(7):2194-2197
53. Taha D. Hyperlipidemia in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2002;15(suppl 1):505-507
54. Bronson-Castain KW, Bearse MA, Jr, Neuville J, et al. Adolescents with type 2 diabetes: Early indications of focal retinal neuropathy, retinal thinning, and venular dilation. Retina. 2009;29(5):618-626
55. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286(10):1195-1200
56. Yokoyama H, Okudaira M, Otani T, et al. Existence of early-onset NIDDM Japanese demonstrating severe diabetic complications. Diabetes Care. 1997;20(5):844-847
57. Okudaira M, Yokoyama H, Otani T, Uchigata Y, Iwamoto Y. Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese type 2 diabetes. J Diabetes Complications. 2000;14(5):281-287
58. Krakoff J, Lindsay RS, Looker HC, Nelson RG, Hanson RL, Knowler WC. Incidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care. 2003;26(1):76-81
59. Farah SE, Wals KT, Friedman IB, Pisacano MA, DiMartino-Nardi J. Prevalence of retinopathy and microalbuminuria in pediatric type 2 diabetes mellitus. J Pediatr Endocrinol Metab. 2006;19(7):937-942
60. Karabouta Z, Barnett S, Shield JP, Ryan FJ, Crowne EC. Peripheral neuropathy is an early complication of type 2 diabetes in adolescence. Pediatr Diabetes. 2008;9(2):110-114
61. Executive summary: Standards of medical care in diabetes-2009 [published correction appears in Diabetes Care. 2009;32(4): 754]. Diabetes Care. 2009;32(suppl 1):S6-S12
62. Svensson M, Sundkvist G, Arnqvist HJ, et al Diabetes Incidence Study in Sweden (DISS). Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: Results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care. 2003;26(10):2903-2909
63. Yokoyama H, Okudaira M, Otani T, et al. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in earlyonset diabetes in Japan. Kidney Int. 2000;58 (1):302-311
64. Mogensen CE, Keane WF, Bennett PH, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 1995;346(8982):1080- 1084
65. Molitch ME, DeFronzo RA, Franz MJ, et al American Diabetes Association. Nephropathy in diabetes. Diabetes Care. 2004;27 (suppl 1):S79-S83
66. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care. 2010;33(suppl 1):S11-S61
67. Kovacs M, Goldston D, Obrosky DS, Bonar LK. Psychiatric disorders in youths with IDDM: Rates and risk factors. Diabetes Care. 1997;20(1):36-44
68. Lawrence JM, Standiford DA, Loots B, et al SEARCH for Diabetes in Youth Study. Prevalence and correlates of depressed mood among youth with diabetes: The SEARCH for Diabetes in Youth study. Pediatrics. 2006; 117(4):1348-1358
69. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994
70. Radloff LS. The CES-D scale: A self report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401
71. Garrison CZ, Jackson KL, Marsteller F, McKeown R, Addy C. A longitudinal study of depressive symptomatology in young adolescents. J Am Acad Child Adolesc Psychiatry. 1990;29(4):581-585
72. Killen JD, Hayward C, Wilson DM, et al. Factors associated with eating disorder symptoms in a community sample of 6th and 7th grade girls. Int J Eat Disord. 1994; 15(4):357-367
73. Roberts RE, Chen YW. Depressive symptoms and suicidal ideation among Mexicanorigin and Anglo adolescents. J Am Acad Child Adolesc Psychiatry. 1995;34(1):81-90
74. Schoenbach VJ, Kaplan BH, Wagner EH, Grimson RC, Miller FT. Prevalence of self-reported depressive symptoms in young adolescents. Am J Public Health. 1983;73(11):1281-1287
75. Egede LE, Ye X, Zheng D, Silverstein MD. The prevalence and pattern of complementary and alternative medicine use in individuals with diabetes. Diabetes Care. 2002;25(2): 324-329
76. Dham S, Shah V, Hirsch S, Banerji MA. The role of complementary and alternative medicine in diabetes. Curr Diab Rep. 2006;6 (3):251-258
77. Dannemann K, Hecker W, Haberland H, et al. Use of complementary and alternative medicine in children with type 1 diabetes mellitus-prevalence, patterns of use, and costs. Pediatr Diabetes. 2008;9(3 pt 1):228-235
78. Geil P, Shane-McWhorter L. Dietary supplements in the management of diabetes: Potential risks and benefits. J Am Diet Assoc. 2008;108(4 suppl 1):S59-S65
79. Miller JL, Cao D, Miller JG, Lipton RB. Correlates of complementary and alternative medicine (CAM) use in Chicago area children with diabetes (DM). Prim Care Diabetes. 2009;3(3):149-156